Synthetic oligosaccharides can replace animal-sourced low–molecular weight heparins
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic oligosaccharides can replace animal-sourced low–molecular weight heparins
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 9, Issue 406, Pages eaan5954
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-09-07
DOI
10.1126/scitranslmed.aan5954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravascular hemolysis and the pathophysiology of sickle cell disease
- (2017) Gregory J. Kato et al. JOURNAL OF CLINICAL INVESTIGATION
- Structure Based Substrate Specificity Analysis of Heparan Sulfate 6-O-Sulfotransferases
- (2016) Yongmei Xu et al. ACS Chemical Biology
- Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program
- (2016) K. E. McGowan et al. BLOOD
- Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA
- (2016) Manu Thomas Kalathottukaren et al. BLOOD
- Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis
- (2016) I. Mahé et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
- (2016) Maureen A. Smythe et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism
- (2016) Brendan P. McDonnell et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- The US regulatory and pharmacopeia response to the global heparin contamination crisis
- (2016) Anita Y Szajek et al. NATURE BIOTECHNOLOGY
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
- (2016) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin
- (2016) Jack E. Ansell et al. THROMBOSIS RESEARCH
- Assessment of Venous Thrombosis in Animal ModelsSignificance
- (2015) Steven P. Grover et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice
- (2015) P. I. Arumugam et al. BLOOD
- Sickle cell disease: renal manifestations and mechanisms
- (2015) Karl A. Nath et al. Nature Reviews Nephrology
- Heparin-Induced Thrombocytopenia
- (2015) Andreas Greinacher NEW ENGLAND JOURNAL OF MEDICINE
- Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
- (2015) Deborah M. Siegal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease
- (2014) E. M. Sparkenbaugh et al. BLOOD
- Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides
- (2014) Po-Hung Hsieh et al. GLYCOBIOLOGY
- Synthetic oligosaccharides as active pharmaceutical ingredients: Lessons learned from the full synthesis of one heparin derivative on a large scale
- (2014) Pierre-Alexandre Driguez et al. NATURAL PRODUCT REPORTS
- Chemoenzymatic synthesis of heparan sulfate and heparin
- (2014) Jian Liu et al. NATURAL PRODUCT REPORTS
- Homogeneous low-molecular-weight heparins with reversible anticoagulant activity
- (2014) Yongmei Xu et al. Nature Chemical Biology
- Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants
- (2014) R. A. Shenoi et al. Science Translational Medicine
- Interplay between coagulation and vascular inflammation in sickle cell disease
- (2013) Erica Sparkenbaugh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Scientific considerations in the review and approval of generic enoxaparin in the United States
- (2013) Sau Lee et al. NATURE BIOTECHNOLOGY
- A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
- (2013) Genmin Lu et al. NATURE MEDICINE
- Top-Down Approach for the Direct Characterization of Low Molecular Weight Heparins Using LC-FT-MS
- (2012) Lingyun Li et al. ANALYTICAL CHEMISTRY
- Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease
- (2012) P. Chantrathammachart et al. BLOOD
- Prevention of VTE in Nonsurgical Patients
- (2012) Susan R. Kahn et al. CHEST
- A Comparison of the Pharmacodynamic Behavior of Branded and Biosimilar Enoxaparin in Primates
- (2012) Walter Jeske et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Synthetic heparin
- (2012) Robert J Linhardt et al. CURRENT OPINION IN PHARMACOLOGY
- Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities
- (2012) Yongmei Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate
- (2011) X. Zhou et al. GLYCOBIOLOGY
- Renal Profiles of Anticoagulants
- (2011) Sebastian Harder JOURNAL OF CLINICAL PHARMACOLOGY
- The induction of macrophage hemeoxygenase-1 is protective during acute kidney injury in aging mice
- (2011) David A. Ferenbach et al. KIDNEY INTERNATIONAL
- Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
- (2011) Y. Xu et al. SCIENCE
- Chemoenzymatic Design of Heparan Sulfate Oligosaccharides
- (2010) Renpeng Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enzymatic route to preparative-scale synthesis of UDP–GlcNAc/GalNAc, their analogues and GDP–fucose
- (2010) Guohui Zhao et al. Nature Protocols
- Oversulfated Chondroitin Sulfate: Impact of a Heparin Impurity, Associated with Adverse Clinical Events, on Low-Molecular-Weight Heparin Preparation
- (2008) Zhenqing Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Solution Structures of Chemoenzymatically Synthesized Heparin and Its Precursors
- (2008) Zhenqing Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Engineering sulfotransferases to modify heparan sulfate
- (2008) Ding Xu et al. Nature Chemical Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More